11/26/2024
Anapharm Bioanalytics Recognized as an Innovative SME
We are thrilled to announce that Anapharm Bioanalytics has recently been officially recognized as an Innovative SME (PYME Innovadora) by the Spanish Ministry of Science and Innovation.
This accreditation highlights our ongoing efforts to advance bioanalytical services through continuous investment in research and development (R&D) and cutting-edge innovation. As a client-focused bioanalytical contract research organization (CRO), we proudly support biotech and pharmaceutical development accross all stages—from early preclinical studies to clinical research.
Being accredited as an Innovative SME reflects not only our commitment to staying at the forefront of bioanalytics but also our ability to adapt to the evolving needs of the biotech and pharmaceutical industries. This recognition further validates our dedication to delivering high-quality, efficient, and reliable services that accelerate drug development timelines.
At Anapharm Bioanalytics, innovation is at the core of everything we do. From offering state-of-the-art bioanalytical services to accelerating drug development timelines, we are proud to contribute to the development of life-saving therapies.
As your trusted partner, we are here to help you navigate the complexities of drug development and bring new treatments to market faster.
Join us on our journey of advancing global healthcare through innovative bioanalytical solutions. Contact us today to learn how our expertise can support your drug development needs.
MORE NEWS
Peptides Series: Understanding Therapeutic Peptides
Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.
The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics
Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.
Overcoming Matrix Effects in the Analysis of Lipophilic Compounds
At the 10th EBF Young Scientist Symposium, we highlighted the complexities of analysing Fucoxanthin derivatives and demonstrated how innovative approaches, such as 2D Chromatography, can overcome these obstacles.